{
    "organizations": [],
    "uuid": "11fdf927da945f63c5eb0595e3b747f2395c8c64",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-683-capital-management-reports-218/brief-683-capital-management-reports-21-8-pct-stake-in-onconova-therapeutics-idUSFWN1Q61G6",
    "ord_in_thread": 0,
    "title": "BRIEF-683 Capital Management Reports 21.8 Pct Stake In Onconova Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 16 (Reuters) - Onconova Therapeutics Inc:\n* 683 CAPITAL MANAGEMENT LLC REPORTS 21.8 PERCENT STAKE IN ONCONOVA THERAPEUTICS INC AS OF FEB 8 - SEC FILING\n* 683 CAPITAL MANAGEMENT LLC SAYS PURCHASED SECURITIES OF ONCONOVA THERAPEUTICS BASED ON BELIEF THAT SUCH SECURITIES, WHEN PURCHASED, WERE \"UNDERVALUED\" Source text: ( bit.ly/2EPjggl ) Further company coverage:\n ",
    "published": "2018-02-17T06:16:00.000+02:00",
    "crawled": "2018-02-17T00:20:06.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "onconova",
        "therapeutic",
        "inc",
        "capital",
        "management",
        "llc",
        "report",
        "percent",
        "stake",
        "onconova",
        "therapeutic",
        "inc",
        "feb",
        "sec",
        "filing",
        "capital",
        "management",
        "llc",
        "say",
        "purchased",
        "security",
        "onconova",
        "therapeutic",
        "based",
        "belief",
        "security",
        "purchased",
        "undervalued",
        "source",
        "text",
        "company",
        "coverage"
    ]
}